首页|硝呋太尔片联合盐酸环丙沙星栓治疗细菌性阴道炎的临床效果观察

硝呋太尔片联合盐酸环丙沙星栓治疗细菌性阴道炎的临床效果观察

扫码查看
目的 观察细菌性阴道炎患者应用硝呋太尔片联合盐酸环丙沙星栓治疗的有效性.方法 100 例细菌性阴道炎患者,结合就诊顺序划分为盐酸治疗组与联合治疗组,每组 50 例.盐酸治疗组采取盐酸环丙沙星栓治疗,联合治疗组采取硝呋太尔片联合盐酸环丙沙星栓治疗.比较两组症状调整所需时间、炎性因子、血清氧化应激反应指标、不良反应发生情况.结果 联合治疗组白带趋于正常化时间(5.41±1.26)d、阴道瘙痒缓解时间(4.23±1.08)d、黏膜充血缓解时间(7.20±0.69)d、阴道疼痛感消失时间(3.15±0.24)d,均较盐酸治疗组的(8.26±1.20)、(7.16±1.33)、(10.57±0.48)、(6.11±0.42)d短(P<0.05).治疗后,联合治疗组白细胞介素-2(4.12±0.52)ng/ml、白细胞介素-8(1.30±0.24)ng/ml、白细胞介素-13(10.22±1.68)ng/ml,盐酸治疗组白细胞介素-2(7.94±0.12)ng/ml、白细胞介素-8(3.25±0.81)ng/ml、白细胞介素-13(21.44±0.46)ng/ml,联合治疗组白细胞介素-2、白细胞介素-8 以及白细胞介素-13 低于盐酸治疗组(P<0.05).治疗后,联合治疗组丙二醛(3.62±0.12)nmol/ml、血清内皮素-1(53.42±4.16)ng/L、超氧化物歧化酶(95.64±8.88)U/ml、血清一氧化氮(102.36±8.65)μmol/ml,盐酸治疗组丙二醛(4.81±0.05)nmol/ml、血清内皮素-1(64.23±8.15)ng/L、超氧化物歧化酶(82.63±6.49)U/ml、血清一氧化氮(85.42±6.35)μmol/ml,联合治疗组丙二醛、血清内皮素-1 低于盐酸治疗组,超氧化物歧化酶、血清一氧化氮高于盐酸治疗组(P<0.05).联合治疗组不良反应发生率低于盐酸治疗组(P<0.05).结论 临床领域内治疗细菌性阴道炎,要选取硝呋太尔片联合盐酸环丙沙星栓治疗模式,可更好地调整患者不良症状,降低炎性因子和血清应激反应指标等,保障患者治疗安全性,可以大力推广.
Clinical observation of nifuratel tablet combined with ciprofloxacin hydrochloride suppository in the treatment of bacterial vaginitis
Objective To observe the effectiveness of nifuratel tablet combined with ciprofloxacin hydrochloride suppositorics in the treatment of bacterial vaginitis.Methods 100 patients with bacterial vaginitis were divided into hydrochloride treatment group and combined treatment group according to the order of treatment,with 50 cases in each group.The hydrochloride treatment group was treated with ciprofloxacin hydrochloride suppository,and the combined treatment group was treated with nifuratel tablets combined with ciprofloxacin hydrochloride suppository.The time required for symptom-based adjustment,inflammatory factors,serum oxidative stress index and the occurrence of adverse reactions were compared between the two groups.Results In the combined treatment group,the recovery time of leukorrhea was(5.41±1.26)d,the relief time of vaginal pruritus was(4.23±1.08)d,the relief time of mucosal congestion was(7.20±0.69)d,and the relief time of vaginal pain was(3.15±0.24)d,which were shorter than(8.26±1.20),(7.16±1.33),(10.57±0.48),and(6.11±0.42)d in the hydrochloride treatment group(P<0.05).After treatment,the combined treatment group had interleukin-2 of(4.12±0.52)ng/ml,interleukin-8 of(1.30±0.24)ng/ml,interleukin-13 of(10.22±1.68)ng/ml,while the hydrochloride treatment group had interleukin-2 of(7.94±0.12)ng/ml,interleukin-8 of(3.25±0.81)ng/ml,interleukin-13 of(21.44±0.46)ng/ml;the interleukin-2,interleukin-8 and interleukin-13 in the combined treatment group were lower than those in the hydrochloride treatment group(P<0.05).After treatment,the combined treatment group had malondialdehyde of(3.62±0.12)nmol/ml,serum endothelin-1 of(53.42±4.16)ng/L,superoxide dismutase of(95.64±8.88)U/ml,and serum nitric oxide of(102.36±8.65)μmol/ml;the hydrochloride treatment group had malondialdehyde of(4.81±0.05)nmol/ml,endothelin-1 of(64.23±8.15)ng/L,superoxide dismutase of(82.63±6.49)U/ml,and nitric oxide of(85.42±6.35)μmol/ml.The malondialdehyde and endothelin-1 in the combined treatment group were lower than those in the hydrochloride treatment group,and the superoxide dismutase and serum nitric oxide in the combined treatment group were higher than those in the hydrochloride treatment group(P<0.05).The incidence of adverse reactions in the combined treatment group was lower than that in the hydrochloride treatment group(P<0.05).Conclusion In the treatment of bacterial vaginitis,it is necessary to select the treatment mode of nifuratel tablet combined with ciprofloxacin hydrochloride suppository,which can better adjust the patient's adverse symptoms,reduce the inflammatory factor and serum stress response indexes and so on,and guarantee the safety of patient treatment,which can be vigorously promoted.

Nifuratel tabletCiprofloxacin hydrochloride suppositoryBacterial vaginitisPractical value

丁雪松、陈霞、许生花

展开 >

222042 连云港市东方医院妇产科

硝呋太尔片 盐酸环丙沙星栓 细菌性阴道炎 应用价值

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(6)
  • 10